A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...

A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...

Discover how to drive business growth and gain a competitive advantage with AI use cases for manufacturing, retail, ...

An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

The layoffs followed a March announcement by Health Secretary Robert F. Kennedy Jr., who called for a major department overhaul.

When a recession hits or is looming, many companies turn to layoffs in order to preserve cash and maintain flexibility in the face of economic uncertainty. However, new research on U.S. corporations ...